Pfizer Remains Flexible On Consumer Health In Restructuring
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
The adage "the more things change, the more they stay the same" may come to mind for Pfizer's consumer business: it will be a standalone division as part of a restructuring that takes effect in January but it's still for sale.